Episode 54: How Will Gene Therapy and Editing Affect the Healthcare Industry?
Benjamin Isgur, who leads the PwC. Health Research Institute, joins host Dr. Bob Kaiser to discuss the forces that will most powerfully affect the healthcare industry in 2020 and beyond, including truly disruptive medical treatments such as gene and cell therapies and genome editing.
David Dawson, senior vice president of Conifer Health Solutions, joins host Dan Karnuta to discuss the use of artificial intelligence in healthcare-related revenue-cycle management.
Attorneys-at-law Lawrence Laddaga and Dale Turner of the law firm Laddaga-Garrett, P.A, join host Dan Karnuta for a discussion about Medicare Advantage plans in Medicare. They discuss its history, its problems and its future.
Dr. Quinton Nottingham with Virginia Tech University joins host Dan Karnuta for a discussion about medical-legal partnerships. Their discussion explores what MLPs are, their operational frameworks and the ways these patient-centered partnerships can address social determinants of health to improve health outcomes.
Dr. Rita Numerof, who appeared as a guest on Episode 27 of The Business of Healthcare Podcast, returns to discuss with host Dan Karnuta why it remains so difficult for value-based pricing to catch on in the healthcare industry.
Request Information
Thank you for your interest in the Naveen Jindal School of Management, UT Dallas. Tell us a little bit about yourself, and we’ll send you customized information about our programs. We hope to meet you soon.
